GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adynxx Inc (OTCPK:ADYX) » Definitions » E10

Adynxx (Adynxx) E10 : $-96.98 (As of Sep. 2019)


View and export this data going back to 1998. Start your Free Trial

What is Adynxx E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Adynxx's adjusted earnings per share data for the three months ended in Sep. 2019 was $-0.330. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-96.98 for the trailing ten years ended in Sep. 2019.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-07), Adynxx's current stock price is $0.0001. Adynxx's E10 for the quarter that ended in Sep. 2019 was $-96.98. Adynxx's Shiller PE Ratio of today is .


Adynxx E10 Historical Data

The historical data trend for Adynxx's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adynxx E10 Chart

Adynxx Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -162.37 -154.07 -137.37 -121.11 -104.66

Adynxx Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -109.01 -104.66 -102.32 -99.67 -96.98

Competitive Comparison of Adynxx's E10

For the Biotechnology subindustry, Adynxx's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adynxx's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adynxx's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Adynxx's Shiller PE Ratio falls into.



Adynxx E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Adynxx's adjusted earnings per share data for the three months ended in Sep. 2019 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=-0.33/108.3294*108.3294
=-0.330

Current CPI (Sep. 2019) = 108.3294.

Adynxx Quarterly Data

per share eps CPI Adj_EPS
200912 -5.633 91.111 -6.698
201003 0.000 91.821 0.000
201006 0.000 91.962 0.000
201009 0.000 92.162 0.000
201012 -26.250 92.474 -30.751
201103 -26.250 94.283 -30.161
201106 0.000 95.235 0.000
201109 0.000 95.727 0.000
201112 -131.251 95.213 -149.331
201203 0.000 96.783 0.000
201206 -26.250 96.819 -29.371
201209 0.000 97.633 0.000
201212 -28.350 96.871 -31.703
201303 -27.000 98.209 -29.782
201306 -19.800 98.518 -21.772
201309 -18.600 98.790 -20.396
201312 -123.000 98.326 -135.514
201403 -43.800 99.695 -47.594
201406 -23.400 100.560 -25.208
201409 -19.800 100.428 -21.358
201412 -20.400 99.070 -22.307
201503 -28.800 99.621 -31.318
201506 -19.200 100.684 -20.658
201509 -15.600 100.392 -16.833
201512 -9.600 99.792 -10.421
201603 -16.800 100.470 -18.114
201606 10.800 101.688 11.505
201609 -18.300 101.861 -19.462
201612 -36.600 101.863 -38.924
201703 -13.620 102.862 -14.344
201706 -5.580 103.349 -5.849
201709 -3.360 104.136 -3.495
201712 -15.720 104.011 -16.373
201803 -7.140 105.290 -7.346
201806 -1.740 106.317 -1.773
201809 -0.900 106.507 -0.915
201812 -1.500 105.998 -1.533
201903 -1.020 107.251 -1.030
201906 -1.180 108.070 -1.183
201909 -0.330 108.329 -0.330

Add all the adjusted EPS together and divide 10 will get our e10.


Adynxx  (OTCPK:ADYX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Adynxx E10 Related Terms

Thank you for viewing the detailed overview of Adynxx's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Adynxx (Adynxx) Business Description

Traded in Other Exchanges
N/A
Address
100 Pine Street, Suite 500, San Francisco, CA, USA, 94111
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
Executives
Gregory J. Flesher director 19900 MACARTHUR BLVD., SUITE 550, IRVINE CA 92612
Brian H Dovey 10 percent owner ONE PALMER SQUARE, PRINCETON NJ 08542
Donald C. Manning officer: CHIEF MEDICAL OFFICER C/O PACIRA BIOSCIENCES, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Pierre Legault director P.O. BOX 1028, C/O STONE MANAGEMENT LLC, BERWYNE PA 19312
Domain Partners Viii, L.p. 10 percent owner C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542
Dp Viii Associates, L.p. 10 percent owner C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542
Eckard Weber director C/O DOMAIN ASSOCIATES, ONE PALO SQ, PRINCETON NJ 08542
Brian K Halak 10 percent owner C/O DOMAIN ASSOCIATES, ONE PALMER SQUARE, PRINCETON NJ 08542
Nicole Vitullo 10 percent owner 3030 SCIENCE PARK ROAD, SAN DIEGO CA 92121
James C Blair 10 percent owner 5880 PACIFIC CENTER BLVD, SAN DIEGO CA 92121-4204
Jesse I Treu 10 percent owner
Dennis Podlesak director C/O PENINSULA PHARMACEUTICALS, INC., 1751 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Tpg Group Holdings (sbs) Advisors, Inc. 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
James G Coulter 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
David Bonderman 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

Adynxx (Adynxx) Headlines

From GuruFocus

Market Overlooks Alliqua's First MAC Coverage

By Last Financier Last Financier 04-21-2015

CFO of Alliqua BioMedical Inc Buys 2,500 Shares

By Jennifer Chiou Jennifer Chiou 08-12-2015